EX-99.1 2 dex991.htm PRESS RELEASE Press Release

EXHIBIT 99.1

 

N E W S   R E L E A S E

LOGO

 

Contact:

  

Karey L. Witty

     Chief Financial Officer
     (314) 725-4477
      
     Lisa M. Wilson
     Senior Vice President, Investor Relations
     (212) 759-3929

 

CENTENE CORPORATION REPORTS TWENTY-THIRD CONSECUTIVE QUARTER

OF INCREASED PROFITABILITY

 

ST. LOUIS, MISSOURI (April 25, 2005) — Centene Corporation (NYSE: CNC) today announced its financial results for the quarter ended March 31, 2005.

 

First Quarter Highlights

 

Revenues of $332.4 million, a 47% increase from the first quarter of 2004.

 

Earnings from operations of $21.3 million, a 45% increase from the first quarter of 2004.

 

Earnings per diluted share of $0.32, a 33% increase from the first quarter of 2004.

 

Membership growth of 49% from the first quarter of 2004.

 

Operating cash flows of $19.9 million, a 61% increase from the first quarter of 2004.

 

Days in claims payable of 59.7.

 

Signed definitive agreement to acquire Medicaid assets of SummaCare, Inc. in Akron, Ohio; transaction to add approximately 39,000 members.

 

Specialty group awarded a $78 million behavioral health contract in Arizona.

 

Michael F. Neidorff, Centene’s Chairman and Chief Executive Officer, said: “The first quarter of 2005 marked our twenty-third consecutive quarter of consistent earnings growth and was consistent with our expectations. This quarter continued to show strong organic growth in membership of 23%, and combined with acquisition growth of 26%. We are confident that our goal to be a total low-cost producer and our strategy of building a multi-line enterprise will continue to offer predictability and strong long-term growth.


Centene Corporation Reports Twenty-Third Consecutive Quarter Of Increased Profitability

April 25, 2005 / Page 2

 

“We are pleased with the collective progress in our states and in particular the solid year-over-year growth in our Indiana, Texas and Wisconsin markets. The State of Indiana recently announced plans to convert its remaining counties to mandated status by the end of 2005, which will add approximately 150,000 Medicaid eligible members in managed care programs. In Wisconsin, membership growth was solid and the rollout of SSI is underway and will occur throughout 2005. In Kansas, our FirstGuard subsidiary has recently lifted its membership cap, which will allow for future expansion. While Missouri is in the process of finalizing legislation to reduce benefits to Medicaid beneficiaries, we expect these changes will only marginally affect our membership. In Ohio, we are preparing for the close of our SummaCare acquisition, effective May 1, 2005.

 

“In Texas, the service area expansion for the STAR+PLUS (SSI) population is still being reviewed by the legislature and administration. We remain optimistic about the expansion efforts and believe that they will create an opportunity to benefit more recipients while producing cost savings for the state. Although we do not presently have at-risk SSI membership in Texas, we are working to support organizations that do. We are proponents of any change that creates better public policy to protect members and providers, and promotes a more efficient and cost-effective healthcare environment.

 

“We are pleased with the progress in our specialty companies, particularly with the new Arizona contract, which will be effective July 1, 2005, and is expected to generate annualized revenues of approximately $78 million. Giving effect to the Arizona contract, we will have an annual run rate approaching $100 million in this segment, and we expect continuing growth in revenue from our specialty companies,” concluded Neidorff.

 

 

2


Centene Corporation Reports Twenty-Third Consecutive Quarter Of Increased Profitability

April 25, 2005 / Page 3

 

Membership totaled 777,300, a 48.8% increase from 522,400 at March 31, 2004. The following table depicts membership in Centene’s managed care organizations by state at March 31, 2005 and 2004:

 

     2005

   2004

Indiana

   149,900    125,400

Kansas

   94,900   

Missouri

   41,300   

New Jersey

   52,700    54,000

Ohio

   23,900    23,800

Texas

   243,700    154,000

Wisconsin

   170,900    165,200
    
  

TOTAL

   777,300    522,400
    
  

 

The following table depicts membership in Centene’s managed care organizations by member category at March 31, 2005 and 2004:

 

     2005

    2004

 

Medicaid

   588,100     446,900  

SCHIP

   178,500     65,900  

SSI

   10,700 (a)   9,600 (b)
    

 

TOTAL

   777,300     522,400  
    

 

(a) 4,500 at-risk; 6,200 ASO
(b) 4,400 at-risk; 5,200 ASO

 

Statement of Earnings Highlights

 

  - For the first quarter of 2005, revenues increased 47.4% to $332.4 million from $225.5 million in the first quarter of 2004.

 

 

3


Centene Corporation Reports Twenty-Third Consecutive Quarter Of Increased Profitability

April 25, 2005 / Page 4

 

  - The health benefits ratio (HBR), which reflects medical costs as a percent of premium revenues, was 80.9% compared to 81.0% for the same period in 2004. The HBR for the SSI category was 94.6%, and is still expected to be volatile given Centene’s relatively small member base.

 

  - General and administrative (G&A) expenses as a percent of revenues were 12.8% in the first quarter of 2005 compared to 12.6% in the first quarter of 2004.

 

  - Earnings from operations increased 45.2% to $21.3 million from $14.7 million in 2004.

 

  - Net earnings were $14.4 million, or $0.32 per diluted share, compared to $10.1 million, or $0.24 per diluted share, for the first quarter of 2004.

 

Balance Sheet and Cash Flow Highlights

 

At March 31, 2005, the Company held cash and investments of $337.1 million, a portion of which is restricted due to state regulatory requirements. Medical claims liabilities totaled $177.6 million, representing 59.7 days in claims payable. A reconciliation of the Company’s change in days in claims payable from the immediately preceding quarter is presented below:

 

Days in claims payable, December 31, 2004

   66.5  

Effect of full quarter of FirstGuard expense

   (9.4 )

Increase in claims inventory

   2.0  

Increase in physician settlements

   0.4  

Increase in pharmacy payables

   0.2  
    

Days in claims payable, March 31, 2005

   59.7  
    

 

Cash flows from operating activities of $19.9 million for the quarter ended March 31, 2005; a 60.8% increase year-over-year.

 

 

4


Centene Corporation Reports Twenty-Third Consecutive Quarter Of Increased Profitability

April 25, 2005 / Page 5

 

Outlook

 

Karey L. Witty, Centene’s Chief Financial Officer, commented, “For the second quarter of 2005, we expect revenue in the range of $343 million to $346 million, net of experience rebates, and net earnings of $0.33 to $0.34 per diluted share. For the full-year 2005, we anticipate revenue in the range of $1.50 billion to $1.53 billion and net earnings of $1.38 to $1.44 per diluted share. We continue to maintain organic membership growth of 10% to 12%, year-over-year. This guidance reflects the close of our previously announced SummaCare transaction, effective May 1, 2005, as well as our previously announced behavioral health contract award in Arizona, effective July 1, 2005. We anticipate spending approximately $1.5 million during the second quarter in preparation for the Arizona contract effective date. This guidance excludes any impact of the Texas STAR+PLUS (SSI) rollout, the potential impact of any other acquisitions we may undertake during 2005, and expenses related to stock option grants under SFAS 123R. The SEC has delayed our required implementation date of SFAS 123R to January 1, 2006, and we anticipate expensing options commencing on that date.”

 

Conference Call

 

As previously announced, the Company will host a conference call tomorrow, April 26, 2005, at 8:30 a.m. (Eastern Time) to review the financial results for the quarter ended March 31, 2005, and to discuss its business outlook. Michael F. Neidorff and Karey L. Witty will host the conference call. Investors are invited to participate in the conference call by dialing (800) 273-1254 in the United States and Canada, and (706) 679-8592 for international participants, or via a live Internet broadcast at the Company’s website, www.centene.com, under the Investor Relations section. A replay of the call will be available from April 26, 2005, shortly after completion of the call until 11:59 p.m. (Eastern Time) on May 4, 2005 at the aforementioned URL, or by dialing (800) 642-1687 in the United States and (706) 645-9291 from abroad and entering access code 5171495.

 

 

5


Centene Corporation Reports Twenty-Third Consecutive Quarter Of Increased Profitability

April 25, 2005 / Page 6

 

About Centene Corporation

 

Centene Corporation provides multi-line managed care programs and related services to individuals receiving benefits under Medicaid, including Supplemental Security Income (SSI) and the State Children’s Health Insurance Program (SCHIP). The Company operates health plans in Indiana, Kansas, Missouri, New Jersey, Ohio, Texas and Wisconsin. In addition, the Company contracts with other healthcare organizations to provide specialty services including behavioral health, nurse triage and treatment compliance. Information regarding Centene is available via the Internet at www.centene.com.

 

The information provided in the first, second and fourth paragraphs following the bullet listing under “First Quarter Highlights” and in the paragraph under “Outlook” above contain forward-looking statements that relate to future events and future financial performance of Centene. Subsequent events and developments may cause the Company’s estimates to change. The Company disclaims any obligation to update this forward-looking financial information in the future. Readers are cautioned that matters subject to forward-looking statements involve known and unknown risks and uncertainties, including economic, regulatory, competitive and other factors that may cause Centene’s or its industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Actual results may differ from projections or estimates due to a variety of important factors, including Centene’s ability to accurately predict and effectively manage health benefits and other operating expenses, competition, changes in healthcare practices, changes in federal or state laws or regulations, inflation, provider contract changes, new technologies, reduction in provider payments by governmental payors, major epidemics, disasters and numerous other factors affecting the delivery and cost of healthcare. The expiration, cancellation or suspension of Centene’s Medicaid managed care contracts by state governments would also negatively affect Centene.

 

[Tables Follow]

 

 

6


Centene Corporation Reports Twenty-Third Consecutive Quarter Of Increased Profitability

April 25, 2005 / Page 7

 

CENTENE CORPORATION AND SUBSIDIARIES

 

CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

 

    

March 31,

2005


   

December 31,

2004


 
     (Unaudited)        
ASSETS             

Current assets:

                

Cash and cash equivalents

   $ 103,276     $ 84,105  

Premium and related receivables, net of allowances of $145 and $462, respectively

     36,987       31,475  

Short-term investments, at fair value (amortized cost $89,466 and $94,442, respectively)

     89,288       94,283  

Other current assets

     19,689       14,429  
    


 


Total current assets

     249,240       224,292  

Long-term investments, at fair value (amortized cost $124,630 and $117,177, respectively)

     122,536       116,787  

Restricted deposits, at fair value (amortized cost $22,299 and $22,295, respectively)

     21,994       22,187  

Property, software and equipment

     45,264       43,248  

Goodwill

     101,830       101,631  

Other intangible assets

     13,889       14,439  

Other assets

     6,031       5,350  
    


 


Total assets

   $ 560,784     $ 527,934  
    


 


LIABILITIES AND STOCKHOLDERS’ EQUITY             

Current liabilities:

                

Medical claims liabilities

   $ 177,582     $ 165,980  

Accounts payable and accrued expenses

     39,995       31,737  

Unearned revenue

     3,935       3,956  

Current portion of long-term debt and notes payable

     486       486  
    


 


Total current liabilities

     221,998       202,159  

Long-term debt

     42,852       46,973  

Other liabilities

     5,935       7,490  
    


 


Total liabilities

     270,785       256,622  

Stockholders’ equity:

                

Common stock, $.001 par value; authorized 100,000,000 shares; issued and outstanding 41,787,406 and 41,316,122 shares, respectively

     42       41  

Additional paid-in capital

     170,857       165,391  

Accumulated other comprehensive income:

                

Unrealized loss on investments, net of tax

     (1,598 )     (407 )

Retained earnings

     120,698       106,287  
    


 


Total stockholders’ equity

     289,999       271,312  
    


 


Total liabilities and stockholders’ equity

   $ 560,784     $ 527,934  
    


 


 

 

7


CENTENE CORPORATION AND SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF EARNINGS

(In thousands, except share data)

 

    

Three Months Ended

March 31,


 
     2005

    2004

 
     (Unaudited)  

Revenues:

                

Premiums

   $ 330,944     $ 222,690  

Services

     1,432       2,835  
    


 


Total revenues

     332,376       225,525  
    


 


Expenses:

                

Medical costs

     267,756       180,448  

Cost of services

     843       2,016  

General and administrative expenses

     42,459       28,377  
    


 


Total operating expenses

     311,058       210,841  
    


 


Earnings from operations

     21,318       14,684  

Other income (expense):

                

Investment and other income

     2,120       1,510  

Interest expense

     (562 )     (90 )
    


 


Earnings before income taxes

     22,876       16,104  

Income tax expense

     8,465       5,966  
    


 


Net earnings

   $ 14,411     $ 10,138  
    


 


Earnings per share:

                

Basic earnings per common share

   $ 0.35     $ 0.25  

Diluted earnings per common share

   $ 0.32     $ 0.24  

Weighted average number of shares outstanding:

                

Basic

     41,560,587       40,384,018  

Diluted

     44,861,989       43,067,740  

 

 

8


CENTENE CORPORATION AND SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

 

    

Three Months Ended

March 31,


 
     2005

    2004

 
     (Unaudited)  

Cash flows from operating activities:

                

Net earnings

   $ 14,411     $ 10,138  

Adjustments to reconcile net earnings to net cash provided by operating activities—

                

Depreciation and amortization

     2,782       2,271  

Deferred income taxes

     (983 )     (755 )

Tax benefits related to stock options

     2,871       786  

Stock compensation expense

     1,091       19  

Loss (gain) on sale of investments

     10       (253 )

Changes in assets and liabilities—

                

Premium and related receivables

     (5,512 )     (1,326 )

Other current assets

     (4,268 )     (1,476 )

Other assets

     (491 )     13  

Medical claims liabilities

     11,602       3,272  

Unearned revenue

     (21 )     63  

Accounts payable and accrued expenses

     (2,446 )     1,211  

Other operating activities

     831       (1,598 )
    


 


Net cash provided by operating activities

     19,877       12,365  
    


 


Cash flows from investing activities:

                

Purchase of property, software and equipment

     (3,665 )     (2,126 )

Purchase of investments

     (21,767 )     (93,742 )

Sales and maturities of investments

     27,542       69,814  

Acquisitions, net of cash acquired

     —         (6,983 )
    


 


Net cash provided by (used in) investing activities

     2,110       (33,037 )
    


 


Cash flows from financing activities:

                

Reduction of long-term debt and notes payable

     (4,121 )     (363 )

Proceeds from stock options and employee stock purchase plan

     1,390       1,052  

Other financing

     (85 )     —    
    


 


Net cash (used in) provided by financing activities

     (2,816 )     689  
    


 


Net increase (decrease) in cash and cash equivalents

     19,171       (19,983 )
    


 


Cash and cash equivalents, beginning of period

     84,105       64,346  
    


 


Cash and cash equivalents, end of period

   $ 103,276     $ 44,363  
    


 


Interest paid

   $ 692     $ 91  

Income taxes paid

   $ 1,133     $ 3,390  

 

 

9


Centene Corporation Reports Twenty-Third Consecutive Quarter Of Increased Profitability

April 25, 2005 / Page 10

 

CENTENE CORPORATION

 

SUPPLEMENTAL FINANCIAL DATA

 

    

Q1

2005


  

Q4

2004


  

Q3

2004


  

Q2

2004


MEMBERSHIP

                           

Indiana

     149,900      150,600      150,000      132,900

Kansas

     94,900      94,200      —        —  

Missouri

     41,300      41,200      —        —  

New Jersey

     52,700      52,800      53,200      54,000

Ohio

     23,900      23,800      23,500      23,800

Texas

     243,700      244,300      250,200      155,300

Wisconsin

     170,900      165,800      164,700      167,300
    

  

  

  

TOTAL

     777,300      772,700      641,600      533,300
    

  

  

  

Medicaid

     588,100      580,200      479,500      460,300

SCHIP

     178,500      182,100      152,100      63,200

SSI

     10,700      10,400      10,000      9,800
    

  

  

  

TOTAL

     777,300      772,700      641,600      533,300
    

  

  

  

REVENUE PER MEMBER

   $ 142.15    $ 139.38    $ 144.70    $ 145.31

CLAIMS

                           

Period-end inventory

     227,700      150,300      141,200      89,700

Average inventory

     191,900      128,300      96,800      98,800

Period-end inventory per member

     0.29      0.19      0.22      0.17

DAYS IN CLAIMS PAYABLE (a)

     59.7      66.5      57.3      53.5

 

(a) Days in Claims Payable is a calculation of Medical Claims Liabilities at the end of the period divided by average claims expense per calendar day for such period.

 

ANNUALIZED RETURN ON EQUITY (b)

           20.5 %           18.2 %           18.2 %           18.2 %

 

(b) Annualized Return on Equity is calculated as follows: (net income for quarter x 4) divided by ((beginning of period equity + end of period equity) divided by 2).

 

HEALTH BENEFITS RATIO BY CATEGORY:

 

     Three Months Ended
March 31,


 
     2005

     2004

 

Medicaid and SCHIP

   80.7 %    80.6 %

SSI

   94.6      99.3  

Total

   80.9      81.0  

 

 

10


GENERAL AND ADMINISTRATIVE EXPENSE RATIO BY BUSINESS SEGMENT:

 

     Three Months
Ended March 31,


 
     2005

     2004

 

Medicaid Managed Care

   10.8 %    10.4 %

Specialty Services

   50.2      52.9  

Total

   12.8      12.6  

 

MEDICAL CLAIMS LIABILITIES

(In thousands)

 

Four rolling quarters of the changes in medical claims liabilities are summarized as follows:

 

Balance, March 31, 2004

   $ 109,841  

Acquisitions

     24,909  

Incurred related to:

        

Current period

     897,838  

Prior period

     (10,054 )
    


Total incurred

     887,784  
    


Paid related to:

        

Current period

     755,468  

Prior period

     89,484  
    


Total paid

     844,952  
    


Balance, March 31, 2005

   $ 177,582  
    


 

Centene’s claims reserving process utilizes a consistent actuarial methodology to estimate Centene’s ultimate liability. Any reduction in the “Incurred related to: Prior period” claims may be offset as Centene actuarially determines “Incurred related to: Current period.” As such, only in the absence of a consistent reserving methodology would favorable development of prior period claims liability estimates reduce medical costs. Centene believes it has consistently applied its claims reserving methodology in each of the periods presented.

 

11